A synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone... more
A synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone. NCI Thesaurus
Bynfezia; Mycapssa; Sandostatin
Decreased Gastrin Activity; Decreased Glucagon Secretion; Decreased Growth Hormone Secretion; Decreased Insulin Secretion; Decreased Thyroid Stimulating Hormone Secretion; Serotonin Activity Alteration
Somatostatin Receptor Agonists
Sandostatin, Sandostatin LAR (octreotide) dosing, indications, interactions, adverse effects, and more.
Viewing results 1 - 10 of 3,010,000 (0.22 seconds)
Octreotide long-acting injection is used to control acromegaly, carcinoid tumors, and VIP-omas in people who have been successfully treated with octreotide ...
Octreotide is a synthetic version of somatostatin (a somatostatin analogue) and slows down the production of hormones. This helps to control the symptoms of ...
Octreotide is a peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide ...
Sep 15, 2020 ... Octreotide is used to treat acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, ...
Jan 25, 1996 ... Octreotide, the first somatostatin analogue introduced for clinical use, inhibits the release of growth hormone, glucagon, and insulin in ...
Dec 22, 2021 ... Eligible patients were adults aged 18–75 years with acromegaly who were receiving iSRLs (long-acting octreotide or lanreotide autogel) for at ...
USES: Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (such as carcinoid tumors, ...
OCTREOTIDE (ok TREE oh tide) is used to reduce blood levels of growth hormone in patients with a condition called acromegaly. This medicine also reduces ...
Jan 26, 2022 ... Incorrect.Increases in the doses of insulin are necessary for the management of the patient's uncontrolled diabetes but not sufficient at ...
... naturally occurring growth hormone inhibitor somatostatin. Octreotide is used to treat diarrhea and flushing associated with certain types of tumors.